CANCER DIGEST – Aug. 20, 2014 – A drug used to treat leukemia may be useful in slowing or halting cancer spread in other cancers, a new study shows.
The drug, Dasatinib is a type of drug called a protein tyrosine kinase inhibitor (TKI). Tyrosine kinases are proteins that act as chemical messengers to stimulate cancer cells to grow.
